Belitser V A, Varetskaia T V, Kosterin S A
Biokhimiia. 1980 Jan;45(1):157-64.
The specific inhibition of fibrin monomer polymerization by fibrinogen and some of its degradation products shows an unusual concentration dependence. Namely, in a certain region of the inhibitor concentration scale the slope of the activity curve increases considerably with an increase in concentration to reach a high constant steepness. This peculiar relationship indicates that the mechanism of inhibition is rather complicated. It has been assumed that this mechanism includes two steps: the first, preliminary step can presumably consist in an inhibitor induced transformation of fibrin (monomer or rather intermediate polymers), while the second one--a competitively inhibiting complex formation. At low inhibitor concentrations the rate of fibrin transformation is slow and limits the delay in clotting. At higher concentrations the modification is progressively accelerated and its rate gradually ceases, influencing the extent of the inhibition. The second stage, with its linear concentration dependence, becomes therefore exclusively rate-limiting. A kinetic analysis revealed that three molecules of the inhibitor are involved in the fibrin modification act. The theoretical curve obtained on the basis of the two-step model was found to be in good agreement with the experimental data.
纤维蛋白原及其某些降解产物对纤维蛋白单体聚合的特异性抑制表现出异常的浓度依赖性。也就是说,在抑制剂浓度范围的某个区域,活性曲线的斜率随着浓度的增加而显著增加,达到一个高的恒定陡度。这种特殊关系表明抑制机制相当复杂。据推测,该机制包括两个步骤:第一步,初步步骤可能在于抑制剂诱导的纤维蛋白(单体或相当的中间聚合物)转化,而第二步——形成竞争性抑制复合物。在低抑制剂浓度下,纤维蛋白转化速率缓慢,限制了凝血延迟。在较高浓度下,修饰逐渐加速,其速率逐渐停止,影响抑制程度。因此,具有线性浓度依赖性的第二阶段成为唯一的限速阶段。动力学分析表明,三个抑制剂分子参与了纤维蛋白修饰作用。基于两步模型得到的理论曲线与实验数据吻合良好。